Skip to Main Content

Paper Details

Efficacy and Safety of Empagliflozin According to Background Diuretic Use in HFrEF: Post-Hoc Analysis of EMPEROR-Reduced.
JACC Heart Fail
1
2024
CV, EMPEROR, EMPagliflozin, Empagliflozin, HF, HFrEF, Heart Failure, NT-proBNP, Patients, cardiovascular [CV] death, chrOnic heaRt Failure, empagliflozin, furosemide, heart failure, patients
Author NameAffiliation
Gerasimos FilippatosNational and Kapodistrian University of Athens School of Medicine, Athens University Hospital Attikon
Carolyn S P LamDuke-NUS Medical School
Naveed SattarUniversity of Glasgow
  • 1 - 3

Datasets

Release 1.2